INTRODUCTION
Recent biochemical data have improved our understanding of the signal-transduction pathways leading to insulin-stimulated glucose transport and glucose transporter translocation. During the last 2 years, phosphatidylinositol (PI) 3-kinase has emerged as a critical step for such events in CHO cells, isolated brown and white adipocytes and 3T3 LI adipose cells [1] [2] [3] [4] [5] [6] .
Important tools for most of these studies have been the recently described highly specific inhibitors of PI 3-kinase, wortmannin and LY294002 [7, 8] . Wortmannin has been shown to inhibit the lipid and serine kinase activity of PI 3-kinase in the nanomolar concentration range [9, 10] . However, some recent reports have described different isoforms of PI 3-kinase which are less sensitive to wortmannin. The currently characterized mammalian PI 3-kinase is a heterodimer composed of a p85 regulatory subunit and a p 110 catalytic subunit [1 1,12] . There are several regulatory ways proposed for PI 3-kinase activity (reviewed in [13] ), one of them being the binding of p85-SH2 domains to tyrosine-phosphorylated proteins such as the insulin receptor substrate-I [14] [15] [16] [17] [18] [19] [20] . Partially purified PI 3-kinase is inhibited by wortmannin with an IC60 of about 4 nM [21] . In contrast, the yeast Vps34 gene product PI 3-kinase activity and the PI-specific PI 3-kinase from bovine cells are inhibited at concentrations above 1 and 0.1 ,uM wortmannin, respectively [21, 22] . Curiously enough, this latter PI 3-kinase is not activated by phosphotyrosine-containing peptides from insulin receptor substrate-I or platelet-derived growth factor receptor. Recently, a novel mammalian PI 3-kinase has been described which is activated by G-protein fly subunits and inhibited by wortmannin with an IC50 of nearly 200 nM [23] .
transporter expressed in L6E9 and Sol8 myoblasts) in both cell systems. The effect of wortmannin on GLUT1 cellular redistribution was independent of the presence of insulin. The cellular distribution of two structural plasma-membrane components such as fl-integrin or the cl subunit of the Na+-K+-ATPase were unaffected by wortmannin in both the absence and the presence of insulin. As a whole, our results indicate that PI 3-kinase is necessary to basal and insulin-stimulated glucose transport in L6E9 and Sol8 myoblasts. Moreover, immunofluorescence assays suggest that in both cellular models there is a constitutive GLUT 1 trafficking pathway (independent of insulin) that involves PI 3-kinase and which, when blocked, locks GLUTI in a perinuclear compartment.
In CHO cells, smooth-muscle cells, platelets, neutrophils, Tcells and rat adipocytes, PI 3-kinase activation has been shown to increase PI 3, [20, [24] [25] [26] [27] . For this reason, it has been suggested that PI(3,4)P2 and PI(3,4,5)P3, but not PI(3)P, may mediate the signalling induced by PI 3-kinase activation. Indeed, very recently, Toker et al. [28] have reported that PI(3,4)P2 and PI(3,4,5)P3 could act as second messengers to activate PKC 8, e or I in vivo. However, in intact soleus muscle incubated with [32P]P , insulin increased the labelling of PI(3)P without any detectable production of PI(3,4)P2 or PI(3,4,5)P3 [291. These observations raise important questions regarding the role of each lipid product of PI 3-kinase in the regulation of distinct cellular functions. In this context, data accumulated lead to the notion that PI(3,4)P2 and PI(3,4,5)P3 may act as second messengers to signal cell proliferation in response to growth factor stimulation [30] , whereas PI(3)P would be specifically involved in regulating intracellular protein-sorting processes [22] .
In this paper, we have used wortmannin to assess the role of PI (Figure 1 ). As seen in Figure 1 for the insulin-treated myoblasts, the effect of chloroform/methanol wortmannin was dose-dependent, with an almost total suppression of PI 3-kinase activity at a concentration of 100 nM. The product of the PI kinase reaction catalysed by the anti-p85 immunoprecipitates was PI(3)P only; no PI(4)P was generated during the incubation, indicating that the immunoprecipitates were not contaminated with PI 4-kinase (results not shown). Thus, myoblasts exhibited basal and insulin-stimulated PI 3-kinase activity, both of which were inhibited by wortmannin.
Wortmannin inhibits basal and insulin-stimulated 2-deoxyglucose uptake in muscle cells We studied the effect of wortmannin on 2-deoxyglucose uptake under basal and insulin-stimulated conditions in L6E9 and Sol8 myoblasts. L6E9 and Sol8 myoblasts express GLUTI as the main glucose carrier isoform, and myogenesis leads to the induction of GLUT4 and GLUT3 in L6E9, but only GLUT4 in Sol8 (F. Vifials, T. Santalucia and P. Kaliman, unpublished work). In the absence ofwortmannin, L6E9 myoblasts responded to insulin by stimulating the rate of 2-deoxyglucose uptake by 63 % (Figure 2a) . The presence of wortmannin caused a dosedependent inhibition of basal and insulin-stimulated 2-deoxyglucose uptake in L6E9 myoblasts (Figure 2a) . The concentration of wortmannin causing a 50% inhibition of basal or insulin-stimulated glucose transport was approx. 10 nM and 20 nM for basal and insulin-stimulated glucose transport, respectively. These values are comparable with those previously found in other cell types, such as adipocytes or Xenopus oocytes [3, 35] . The effect of wortmannin on basal and insulin-stimulated glucose transport was also evaluated in Sol8 myoblasts, a mouse skeletal-muscle cell line. In keeping with the observations in rat L6E9 cells, Sol8 myoblasts responded to insulin by stimulation of 2-deoxyglucose uptake, and wortmannin inhibited both basal and insulin-stimulated glucose transport in a dose-dependent manner (Figure 2b ).
Wortmannin induces a major cellular redistribution of GLUT1 glucose carriers in myoblasts
On the basis of the inhibitory effect of wortmannin on glucose transport activity in muscle cells, we aimed to determine, in the Wortmannin (nM) Figure 2 inhibitlon by wortmannin of basal and Insulin-stimulated 2-deoxyglucose uptake by L6E9 and Sol8 myoblasts After serum starvation, L6E9 (a) and Sol8 (b) myoblasts were incubated for 1 h at various concentrations of wortmannin in the absence (black symbols or black bars) or in the presence of 1 ,uM insulin (white symbols or white bars). After addition of 0.1 mM 2-deoxy[3H]glucose, the cellular hexose uptake at t= 20 min was measured as described in the Materials and methods section. (a) and (b) show the means of three independent experiments where each point was done in triplicate. next step, whether this effect of wortmannin was a consequence of the redistribution of glucose carriers. In order to answer this question, L6E9 and Sol8 myoblasts were incubated for 1 h in the absence or presence of wortmannin with the addition (or not) of insulin during the last 30 min of incubation. The distributions of fl1-integrin and the al subunit of the Na+-K+-ATPase (plasmamembrane markers) and GLUTI were then determined by immunofluorescence analysis.
In L6E9 myoblasts, a substantial proportion of GLUTI was distributed on the cell surface, on the basis of the similar immunofluorescence pattern found for /,-integrin, the a, subunit of the Na+-K+-ATPase and GLUTI (Figures 3a, 3d and 4) . Indeed, all three antibodies used clearly delineated the cell borders. Under our experimental conditions, we were not able to detect any effect of insulin compatible with a process of GLUTI translocation to the cell surface. After exposure to wortmannin, most GLUTI was found intracellularly, and a marked decrease in the immunofluorescence associated with the cell surface was detected both in the absence and in the presence of insulin ( Figure Immunofluorescence results in Sol8 myoblasts totally coincided with the results obtained in L6E9 myoblasts: (i) GLUT1 was detected on the cell surface, and no effect of insulin on GLUTI distribution could be observed under our experimental conditions ( Figures 5a and 5d) ; (ii) wortmannin caused a redistribution of GLUTI from the cell surface to an intracellular perinuclear locus ( In summary, immunofluorescence data from L6E9 and Sol8 myoblasts suggest that PI 3-kinase inhibition by wortmannin affects a GLUT1 trafficking pathway that is already active in the absence ofinsulin. Furthermore, the alteration ofthe intracellular distribution of GLUTI by wortmannin appears to be specific, since no change in the distribution of two cell-surface markers such as the al subunit of the Na+-K+-ATPase and /51-integrin could be detected after wortmannin treatment.
DISCUSSION
In this paper we have analysed the effect of the highly specific inhibitor of PI 3-kinase, wortmannin, on glucose transport and GLUT1 glucose carrier trafficking in myoblasts from two skeletal-muscle cell lines, L6E9 and Sol8. L6E9 myoblasts exhibited basal and insulin-sensitive PI 3-kinase activities which were inhibited in vivo by wortmannin, as detected in solubilized cell preparations immunoprecipitated with anti-p85 antibodies, using PI as a substrate. In contrast with what is reported for other cell types, such as white and brown adipocytes [2, 4] and Effect of wortmannin on glucose carrier distribution in myoblasts 3T3-LI cells [3] , in which wortmannin altered only the insulinstimulated component of glucose transport, myoblasts of both cell lines studied here (L6E9 and Sol8) responded to wortmannin by decreasing both the basal and the insulin-stimulated rate of 2-deoxyglucose uptake in a dose-dependent manner. Germane to this issue is the report that another inhibitor of PI 3-kinase activity, LY294002, has been shown to decrease both basal and insulin-stimulated glucose transport in 3T3-L1 cells [5, 36] . These observations raised the question of the mechanism by which basal glucose transport activity was altered in myoblast cells in response to wortmannin. Based on the fact that GLUT1 is the predominant glucose carrier expressed in L6E9 and Sol8 myoblasts, we focused on the effect of wortmannin on the cell distribution of GLUT1. In keeping with its effects on glucose transport activity, wortmannin caused a dramatic alteration in the distribution of GLUT1 in L6E9 and Sol8 myoblasts, in the absence or presence of insulin. Thus, whereas under basal conditions GLUT1 shows a pattern of distribution characteristic of a cell-surface protein marker, in the presence of wortmannin most GLUTI was redistributed to an intracellular perinuclear compartment. Wortmannin caused no detectable effect on the distribution of two cell-surface components such as 81 integrin and the al subunit of the Na+-K+-ATPase. In this regard, the identification of the specific intracellular compartment(s) that contains most of intracellular GLUT1 in the presence of wortmannin deserves further study. In any case, our data strongly suggest that, in muscle cells, PI 3-kinase is already active under basal conditions (in the absence of insulin) and plays an essential role in the intracellular trafficking of GLUT1, and therefore in the basal rate of glucose transport.
Results shown in Figure 2 clearly demonstrate that insulin stimulates glucose transport in L6E9 and Sol8 myoblasts. Based on the fact that the major glucose transporter expressed in myoblasts is GLUTI, the effect of insulin activating glucose transport must be due to translocation of GLUT1 to the cell surface and/or activation of the carriers already present at the plasma membrane. In this regard, insulin-induced translocation of GLUTI to the plasma membrane has been reported in 476 P. Kaliman and others adipocytes [3, 37, 38] . Immunofluorescence analysis performed in this study did not substantiate the existence of GLUTI translocation in L6E9 and Sol8 myoblasts. However, this is not definitive evidence against translocation, since immunofluorescence assays might not allow detection of a redistribution of carriers, leading to a 63 % activation of transport as is observed in myoblasts.
PI 3-kinase activity has been implicated in protein-sorting processes. Thus it has been reported that mutant platelet-derived growth factor receptors specifically lacking the binding site for PI 3-kinase fail to accumulate intracellularly [39] and that mutant colony-stimulating factor receptors that do not associate with PI 3-kinase are internalized, but are not delivered to the lysosome for degradation [40, 41] . In yeast, the Vps34p PI 3-kinase activity has been shown to be essential for vacuolar protein sorting [42] . Recent data from Stack et al. [43] have revealed important aspects of the Vps34p PI 3-kinase activation pathway. They have shown that an intact Vpsl5 protein kinase is necessary for the association with and activation of Vps34p. In fact, a functional Vpsl5-Vps34 complex is absolutely required for the efficient delivery of proteins to the yeast vacuole. In Vps34 mutants lacking PI 3-kinase activity, a dramatic decrease in cellular PI(3)P levels, together with a blockade of vacuolar protein sorting, is observed. In this context, it has been proposed that the phosphorylation ofPI by Vps34p may have the effect ofphysically stimulating membrane curvature and thus facilitating the formation of transport vesicles [44] and/or may recruit or activate proteins involved in the budding or transport of vesicles from the sorting compartment [43] . Based on the fact that Vps34p is a Plspecific PI 3-kinase, it has been suggested that the production of PI(3)P is specifically involved in regulating intracellular proteinsorting pathways [22] . Whether PI(3)P acts in mammalian cells as a second messenger to signal intracellular protein trafficking in a manner similar to that in yeast remains to be determined.
Further studies are required to identify the myoblast isoform(s) of PI 3-kinase which, when inhibited by wortmannin, caused an alteration of GLUTI cellular distribution and an inhibition of glucose transport, under both basal and insulin-stimulated conditions. Some aspects of our results allow us to put forward the idea that the effect of wortmannin on glucose transport and GLUTI redistribution might be related to a myoblast functional homologue of yeast Vps34p and/or bovine PI-specific PI 3-kinase. This is based on the following observations. (i) Mammalian PI-specific PI 3-kinase activity was shown to be insensitive to phosphotyrosine peptides from platelet-derived growth factor receptor or insulin receptor substrate-I [21] . This correlates with the fact that the effect of wortmannin on GLUTI cellular distribution was independent of the presence of insulin. (ii) Similarly to the severe defects in vacuolar protein sorting of yeast strains in which the VPS34 gene had been deleted or those carrying Vps34 point mutations [41, 42] , in myoblasts wortmannin-induced PI 3-kinase inhibition blocked the cellular trafficking of GLUTI.
In conclusion, results presented here, together with the data discussed above, lead to the concept that the regulation of membrane trafficking may be a function of PI 3-kinases in eukaryotic cells. The biochemical characterization of myoblast PI 3-kinase isoforms and products, together with the possible role of a PI 3-kinase activity in the trafficking of other cellular components, is currently under study in our laboratory.
